Proton pump inhibitors have no measurable effect on calcium and bone metabolism in healthy young males: a prospective matched controlled study.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2013-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.metabol.2012.09.011PMID 23102518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

  2012influential reference
• Meta-analysis: risk of fractures with acid-suppressing medication.

  2011cited by this paper
• Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies

  2011influential reference
• Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

  2011cited by this paper
• Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

  2011influential reference
• Do Proton Pump Inhibitors Decrease Calcium Absorption?

  2010influential reference
• Hypovitaminosis D in developing countries—prevalence, risk factors and outcomes

  2010cited by this paper
• Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.

  2010cited by this paper
• Age but not gender modulates the relationship between PTH and vitamin D.

  2010cited by this paper
• Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

  2010cited by this paper
• Effect of age, gender and calciotropic hormones on the relationship between vitamin D receptor gene polymorphisms and bone mineral density

  2010cited by this paper
• Relationship of calcium absorption with 25(OH)D and calcium intake in children with rickets.

  2010cited by this paper
• T1081 The Effect of PPI (Proton Pump Inhibitor) on the Bone Mineral Density, Bone Microstructure and Bone Metabolism of Rat

  2010cited by this paper
• Inhibiting gastric acid production does not affect intestinal calcium absorption in young, healthy individuals: A randomized, crossover, controlled clinical trial

  2010cited by this paper
• Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo.

  2009cited by this paper
• Skeletal and Hormonal Effects of Magnesium Deficiency

  2009cited by this paper
• Hypomagnesemia induced by several proton-pump inhibitors.

  2009cited by this paper
• Use of proton pump inhibitors and risk of osteoporosis-related fractures

  2008cited by this paper
• Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women

  2008cited by this paper
• Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors

  2008cited by this paper
• Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults

  2008cited by this paper
• Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency

  2008cited by this paper
• Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm

  2008cited by this paper
• Proton pump inhibitor therapy and osteoporosis.

  2008cited by this paper
• Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.

  2006cited by this paper
• Calcium absorption and achlorhydria.

  2006cited by this paper
• Long-term proton pump inhibitor therapy and risk of hip fracture.

  2006cited by this paper
• Proton-pump inhibitors and hypomagnesemic hypoparathyroidism.

  2006cited by this paper
• Low calcium and vitamin D intake in healthy children and adolescents and their correlates

  2005cited by this paper
• Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.

  2005cited by this paper
• Effects of magnesium deficiency on strength, mass, and composition of rat femur

  2004cited by this paper
• A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults.

  2004cited by this paper
• Who is Using Chronic Acid Suppression Therapy and Why?

  2003cited by this paper
• The burden of selected digestive diseases in the United States.

  2002cited by this paper
• Short-Term Omeprazole Treatment Does Not Influence Biochemical Parameters of Bone Turnover in Children

  2002cited by this paper
• Calcium and Phosphate Plasma Levels in Dialysis Patients after Dietary Ca-P Overload

  2002cited by this paper
• Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis.

  1998cited by this paper
• Chicken Parathyroid Hormone Gene Expression in Response to Gastrin, Omeprazole, Ergocalciferol, and Restricted Food Intake

  1997cited by this paper
• Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

  1996cited by this paper
• Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.

  1995cited by this paper
• Effect of gastric acid secretion on intestinal phosphate and calcium absorption in normal subjects.

  1995cited by this paper
• Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans

  1993influential reference
• Omeprazole, a specific inhibitor of H+−K+-ATPase, inhibits bone resorptionin vitro

  1986cited by this paper

• Correlation of Fractal Dimensions and Mandibular Cortical Index Assessed Using Panoramic Radiographs in Subjects on Proton Pump Inhibitors Therapy with Serum Biochemical Parameters: A Comparative Cross-Sectional Study

  2025cites this paper
• Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density

  2024cites this paper
• Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.

  2024cites this paper
• Correlation of Demographic Characteristics to Bone Calcium and Vitamin D in Patient taking Proton Pump Inhibitor (PPI)

  2024cites this paper
• Use of Proton Pump Inhibitors and Risk of Fracture in Adults: A Review of Literature

  2023cites this paper
• Quasi Experimental Study to Ascertain Link of PPI to Bone Profile in Healthy Individuals

  2023cites this paper
• Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.

  2023cites this paper
• Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study

  2023cites this paper
• Different effects of chronic omeprazole use on osteoporotic fractures rate in the elderly

  2023cites this paper
• Changes in bone turnover markers in adolescents with gastroesophageal reflux disease treated with lansoprazole.

  2022cites this paper
• Prevalence of Low Serum Alkaline Phosphatase and Hypophosphatasia in Adult Patients with Atypical Femur Fractures

  2022cites this paper
• Proton pump inhibitors and osteoporosis risk: exploring the role of TRPM7 channel

  2021cites this paper
• Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo

  2020cites this paper
• Effect of proton pump inhibitors on dental implants: A systematic review and meta-analysis

  2020cites this paper
• Einfluss von Pantoprazol auf die Frakturheilung im Alter

  2020cites this paper
• Potential proton pump inhibitor–related adverse effects

  2020cites this paper
• Fracture risk of young adults receiving proton‐pump inhibitors and H2‐receptor antagonists

  2019cites this paper
• Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome.

  2018cites this paper
• Proton pump inhibitors’ use and risk of hip fracture: a systematic review and meta-analysis

  2018cites this paper
• Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies

  2018cites this paper
• Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.

  2017cites this paper
• Micronutrient Consequences of Long Term Proton Pump Inhibitor Therapy

  2017cites this paper
• A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long‐Term Safety

  2017cites this paper
• [Proton pump inhibitors and their effect on the bone].

  2016cites this paper
• Proton pump inhibitors and osteoporosis

  2016cites this paper
• Gastric protection or bone protection? The dilemma of proton-pump inhibitor

  2016cites this paper
• Impaired skeletal health in patients with chronic atrophic gastritis

  2016cites this paper
• Skeletal effects of a gastrin receptor antagonist in H+/K+ATPase beta subunit KO mice.

  2016cites this paper
• Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients

  2016cites this paper
• Use of proton pump inhibitors is associated with fractures in young adults: a population-based study

  2015cites this paper
• The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.

  2015cites this paper
• Shifting electrolytes in Proton Pump Inhibitor (PPI)-Induced Hypomagnesemia

  2015cites this paper
• A Proton Pump Inhibitor’s Effect on Bone Metabolism Mediated by Osteoclast Action in Old Age: A Prospective Randomized Study

  2014cites this paper
• Proton Pump Inhibitors: Omeprazole

  2014cites this paper
• The Association Between Drugs Frequently Used by the Elderly and Vitamin D Blood Levels: A Review of Observational and Experimental Studies

  2014cites this paper
• Proton Pump Inhibitors and Risk of Bone Fractures

  2014cites this paper
• The role of the gastrointestinal tract in calcium homeostasis and bone remodeling

  2013cites this paper
• Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.

  2013cites this paper
• PROTON PUMP INHIBITORS BETWEEN BENEFITS AND RISKS

  2013cites this paper